These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21918687)

  • 1. Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease.
    Chen S; Wang JM; Irwin RW; Yao J; Liu L; Brinton RD
    PLoS One; 2011; 6(8):e24293. PubMed ID: 21918687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease.
    Wang JM; Singh C; Liu L; Irwin RW; Chen S; Chung EJ; Thompson RF; Brinton RD
    Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6498-503. PubMed ID: 20231471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.
    Singh C; Liu L; Wang JM; Irwin RW; Yao J; Chen S; Henry S; Thompson RF; Brinton RD
    Neurobiol Aging; 2012 Aug; 33(8):1493-506. PubMed ID: 21803451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.
    Irwin RW; Wang JM; Chen S; Brinton RD
    Front Endocrinol (Lausanne); 2011; 2():117. PubMed ID: 22654847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise.
    Irwin RW; Brinton RD
    Prog Neurobiol; 2014 Feb; 113():40-55. PubMed ID: 24044981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.
    Wang JM; Irwin RW; Liu L; Chen S; Brinton RD
    Curr Alzheimer Res; 2007 Dec; 4(5):510-7. PubMed ID: 18220513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
    Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
    Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regenerative potential of allopregnanolone.
    Wang JM; Liu L; Irwin RW; Chen S; Brinton RD
    Brain Res Rev; 2008 Mar; 57(2):398-409. PubMed ID: 17931704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease.
    Brinton RD; Wang JM
    Curr Alzheimer Res; 2006 Feb; 3(1):11-7. PubMed ID: 16472197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent.
    Brinton RD; Wang JM
    Curr Alzheimer Res; 2006 Jul; 3(3):185-90. PubMed ID: 16842093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.
    Sun C; Ou X; Farley JM; Stockmeier C; Bigler S; Brinton RD; Wang JM
    Curr Alzheimer Res; 2012 May; 9(4):473-80. PubMed ID: 22272610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer's Disease.
    Chen S; Wang T; Yao J; Brinton RD
    Neurotherapeutics; 2020 Oct; 17(4):1813-1824. PubMed ID: 32632771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential.
    Wang JM; Brinton RD
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S11. PubMed ID: 19090984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.
    Yao J; Chen S; Mao Z; Cadenas E; Brinton RD
    PLoS One; 2011; 6(7):e21788. PubMed ID: 21747957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model.
    Wang T; Yao J; Chen S; Mao Z; Brinton RD
    Neurotherapeutics; 2020 Jan; 17(1):178-188. PubMed ID: 31664643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.
    Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH
    Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.